A detailed history of Ostrum Asset Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ostrum Asset Management holds 12,975 shares of EW stock, worth $856,220. This represents 0.1% of its overall portfolio holdings.

Number of Shares
12,975
Previous 19,840 34.6%
Holding current value
$856,220
Previous $1.9 Billion 36.78%
% of portfolio
0.1%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$84.3 - $94.31 $578,719 - $647,438
-6,865 Reduced 34.6%
12,975 $1.2 Billion
Q4 2023

Feb 13, 2024

BUY
$61.71 - $77.76 $570,694 - $719,124
9,248 Added 87.31%
19,840 $1.51 Billion
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $390,115 - $525,822
-5,631 Reduced 34.71%
10,592 $734 Million
Q2 2023

Aug 11, 2023

BUY
$81.41 - $94.33 $3,337 - $3,867
41 Added 0.25%
16,223 $1.53 Billion
Q1 2023

May 12, 2023

BUY
$74.26 - $84.51 $1.2 Million - $1.37 Million
16,182 New
16,182 $1.34 Billion

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Ostrum Asset Management Portfolio

Follow Ostrum Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ostrum Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Ostrum Asset Management with notifications on news.